Wall Street bets on baldness drugs as next big opportunity after GLP‑1

Wall Street is shifting focus from GLP‑1 weight‑loss stocks to baldness drugs, viewing them as the next potential goldmine. The trend highlights a new area of investment interest beyond the current GLP‑1 boom.